The Federal Trade Commission has launched an investigation into the role of hospital group purchasing organizations and dominant wholesalers in causing decades-long shortages of hundreds of lifesaving drugs.
In the July 19 article “Platinum drugs are off the shortage list, but the underlying problem is unsolved,” FDA Commissioner Robert Califf and others describe a solution to the U.S. drug shortage as a matter of paying more for generic drugs.
